Atlas Trials

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

Clinical trial NCT00030485 · COMPLETED

Trial details

NCT number
NCT00030485
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2002-01-01
Primary completion
2007-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.